Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
World Journal of Urology|February 11, 2018
Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre studyJean-Baptiste Beauval, Benoit Peyronnet, Thibaut Benoit, et al.
European Urology Oncology|August 20, 2022
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell CarcinomaZine-Eddine Khene, Pierre Bigot, Nicolas Doumerc, et al.
World Journal of Urology|January 6, 2026
First-line treatments for BCG-naïve non-muscle invasive bladder cancer: a systematic review and meta-analysisNavid Roessler, Brigida A Maiorano, Marcin Miszczyk, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 21, 2022
StomaCare: quality of life impact after enhanced follow-up of ostomy patients by a home healthcare nursing service-a multicentre, randomized, controlled trialCharles de Ponthaud, Morgan Roupret, Dewi Vernerey, et al.
Trials|August 18, 2023
Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)Gaelle Margue, Pierre Bigot, Alexandre Ingels, et al.
The Journal of Urology|September 25, 2016
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future DirectionGrant P Redrow, Charles C Guo, Maurizio A Brausi, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldEva Compérat, Stéphane Larré, Morgan Roupret, et al.
World Journal of Urology|February 11, 2018
Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre studyJean-Baptiste Beauval, Benoit Peyronnet, Thibaut Benoit, et al.
European Urology Oncology|August 20, 2022
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell CarcinomaZine-Eddine Khene, Pierre Bigot, Nicolas Doumerc, et al.
World Journal of Urology|January 6, 2026
First-line treatments for BCG-naïve non-muscle invasive bladder cancer: a systematic review and meta-analysisNavid Roessler, Brigida A Maiorano, Marcin Miszczyk, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 21, 2022
StomaCare: quality of life impact after enhanced follow-up of ostomy patients by a home healthcare nursing service-a multicentre, randomized, controlled trialCharles de Ponthaud, Morgan Roupret, Dewi Vernerey, et al.
Trials|August 18, 2023
Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)Gaelle Margue, Pierre Bigot, Alexandre Ingels, et al.
The Journal of Urology|September 25, 2016
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future DirectionGrant P Redrow, Charles C Guo, Maurizio A Brausi, et al.
Pageof 28